等待开盘 09-17 09:30:00 美东时间
0.000
0.00%
ASCO: new Sarclisa data support subcutaneous administration with on-body injectorNew data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened
06-03 20:29
Sanofi (NASDAQ:SNY) said that a Phase 3 study of its new subcutaneous formulation of Sarclisa in the treatment of multiple myeloma met its co-primary endpoints, demonstrating non-inferiority to the in...
01-10 00:16
本文来源:时代财经 作者:文若楠 行至2024年年末,痤疮药物赛道迎来新的竞争者。 近日,艾棣维欣(苏州)生物制药有限公司(874055.NQ,下称“艾棣维欣...
2024-12-31 16:13
NEW YORK, June 4, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2024-06-05 11:53
Akili press release (NASDAQ:AKLI): Q1 non-GAAP net loss was $9.3 million for the first quarter of 2024, compared to a non-GAAP net loss of $10.8 million for the fourth quarter of 2023. Revenue of $0.3...
2024-05-15 19:25
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling ...
2024-05-01 02:37
U.S. stocks traded lower this morning, with the Dow Jones index falling more th...
2024-04-30 22:17
12月31日,Akili, Inc.(AKLI.US)公布财报,公告显示公司2023财年净利润为-59.49百万美元;其中营业收入为1.68百万美元,每股基本收...
2024-03-08 00:26
Akili (NASDAQ:AKLI) reported quarterly losses of $(0.140) per share which beat the analyst consensus estimate of $(0.210) by 33.33 percent. The company reported quarterly sales of $749.000 thousand which missed the
2024-03-01 06:42
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
2024-02-29 18:15